Ultra-short course, high-dose primaquine to prevent Plasmodium vivax infection following uncomplicated pediatric malaria: A randomized, open-label, non-inferiority trial of early versus delayed treatment.

Woon SA, Moore BR, Laman M, Tesine P, Lorry L, Kasian B, Yambo P, Yadi G, Pomat W, Batty KT, Salman S, Robinson LJ, Davis TME, Manning L

Open source

DOI: 10.1016/j.ijid.2023.03.010
Published: 2023 May
Container: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Publisher: Not recorded
Open access: no

Credibility signals

uncertain Score 51/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ijid.2023.03.010,
  title = {Ultra-short course, high-dose primaquine to prevent Plasmodium vivax infection following uncomplicated pediatric malaria: A randomized, open-label, non-inferiority trial of early versus delayed treatment.},
  author = {Woon SA and Moore BR and Laman M and Tesine P and Lorry L and Kasian B and Yambo P and Yadi G and Pomat W and Batty KT and Salman S and Robinson LJ and Davis TME and Manning L},
  year = {2023},
  journal = {International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases},
  doi = {10.1016/j.ijid.2023.03.010},
  url = {https://doi.org/10.1016/j.ijid.2023.03.010}
}

RIS

TY  - JOUR
TI  - Ultra-short course, high-dose primaquine to prevent Plasmodium vivax infection following uncomplicated pediatric malaria: A randomized, open-label, non-inferiority trial of early versus delayed treatment.
AU  - Woon SA
AU  - Moore BR
AU  - Laman M
AU  - Tesine P
AU  - Lorry L
AU  - Kasian B
AU  - Yambo P
AU  - Yadi G
AU  - Pomat W
AU  - Batty KT
AU  - Salman S
AU  - Robinson LJ
AU  - Davis TME
AU  - Manning L
PY  - 2023
JO  - International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
DO  - 10.1016/j.ijid.2023.03.010
UR  - https://doi.org/10.1016/j.ijid.2023.03.010
ER  -

APA

SA, W., BR, M., M, L., P, T., L, L., B, K., P, Y., G, Y., W, P., KT, B., S, S., LJ, R., TME, D., & L, M. (2023). Ultra-short course, high-dose primaquine to prevent Plasmodium vivax infection following uncomplicated pediatric malaria: A randomized, open-label, non-inferiority trial of early versus delayed treatment.. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. https://doi.org/10.1016/j.ijid.2023.03.010

Source records

pubmed · retrieved 2026-09-26T17:57:20.009Z
europe-pmc · retrieved 2026-09-26T17:57:20.017Z
doaj · retrieved 2026-09-26T17:57:20.016Z